Evidence map›Paper›PMID 41428073›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2026

Influence of the level of education on cognitive function in Parkinson's disease.

Diego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, María Cristina Íñiguez Alvarado, Lucía Samaniego, Antón López Maside, Lucía Gallego, Laura Couce Barreiro, Javier Rodríguez Caramés, Maria J Feal Painceiras and 37 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Diego Santos-GarcíaDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain. diegosangar@yahoo.es.
Teresa de Deus FonticobaCHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain.
Carlos Cores BartoloméDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
María Cristina Íñiguez AlvaradoDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Lucía SamaniegoDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Antón López MasideDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Lucía GallegoDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Laura Couce BarreiroDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Javier Rodríguez CaramésDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Maria J Feal PainceirasDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Jose Manuel Paz GonzálezDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006, A Coruña, Spain.
Silvia JesúsServicio de Neurología y Neurofisiología Clínica, Unidad de Trastornos del MovimientoInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSICUniversidad de Sevilla, Seville, Spain.
Marina CosgayaHospital Clínic de Barcelona, Barcelona, Spain.
Juan García CaldenteyCentro Neurológico Oms 42, Palma, Spain.
Nuria CaballolConsorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain.
Ines LegardaHospital Universitario Son Espases, Palma, Spain.
Jorge Hernández VaraCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Iria CaboComplejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
Lydia López ManzanaresHospital Universitario La Princesa, Madrid, Spain.
Isabel González AramburuCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Maria A Ávila RiveraConsorci Sanitari Integral, Hospital General de L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.
Víctor Gómez MayordomoNeurology Department, Institute of Neuroscience, Vithas Madrid La Milagrosa University Hospital, Vithas Hospital Group, Madrid, Spain.
Víctor NogueiraHospital Universitario Lucus Augusti, Lugo, Spain.
Julio Dotor García-SotoHospital Universitario Virgen Macarena, Seville, Spain.
Carmen BorruéHospital Infanta Sofía, Madrid, Spain.
Berta Solano VilaInstitut d'Assistència Sanitària (IAS), Institut Català de la Salut, Girona, Spain.
María Álvarez SaucoHospital General Universitario de Elche, Elche, Spain.
Lydia VelaFundación Hospital de Alcorcón, Madrid, Spain.
Sonia EscalanteHospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain.
Esther CuboComplejo Asistencial Universitario de Burgos, Burgos, Spain.
Zebenzui MendozaHospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, Spain.
Isabel PareésHospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Pilar Sánchez AlonsoHospital Universitario Puerta de Hierro, Madrid, Spain.
Maria G Alonso LosadaHospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.
Nuria López ArizteguiComplejo Hospitalario de Toledo, Toledo, Spain.
Itziar GastónComplejo Hospitalario de Navarra, Pamplona, Spain.
Jaime KulisevskyCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Manuel SeijoComplejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
Caridad ValeroHospital Arnau de Vilanova, Valencia, Spain.
Ruben Alonso RedondoHospital Universitario Lucus Augusti, Lugo, Spain.
Maria Teresa BuongiornoHospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain.
Carlos OrdásHospital Rey Juan Carlos, Madrid, Spain.
Manuel Menéndez-GonzálezHospital Universitario Central de Asturias, Oviedo, Spain.
Darrian McAfeeUniversity of Maryland School of Medicine, Baltimore, USA.
Pablo Martinez-MartinCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Madrid, Spain.
Pablo MirServicio de Neurología y Neurofisiología Clínica, Unidad de Trastornos del MovimientoInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSICUniversidad de Sevilla, Seville, Spain.
COPPADIS Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Level of Education (LoE) is widely used as an indicator of cognitive reserve and is associated with risk of dementia. The aim of the present study was to know the influence of the LoE on cognitive function (CF) in patients with Parkinson´s disease (PD). Controls and PD patients from the Spanish cohort COPPADIS with a disease duration from symptoms onset ≤ 5 years, who were recruited from January/2016 to November/2017 (baseline visit; V0) and evaluated at 2 (V2), 4 (V4) and 5 (V5) years of follow-up were included. Regarding LoE, patients were classified as with primary, secondary and university education. CF was assessed using the Parkinson´s Disease Cognitive Rating Scale (PD-CRS). General linear model (GLM) repeated measure was used to test for changes in the CF. A p value ≤ 0.005 was considered significant. Three hundred and ninety-nine PD patients (61.9 ± 8.9 years old; 58.4% males) and 207 controls (61 ± 8.3 years old; 49.8% males) were included. From V0 to V5, significant differences were observed in PD patients in global and fronto-subcortical (p < 0.0001 in all visits) between LoE groups but not in posterior-cortical (p > 0.05 in all visits) CF. LoE was associated with the change from V0 to V5 in the PD-CRS total score and fronto-subcortical sub-score (p < 0.0001) in PD patients but not in controls. After adjustment for many covariates, primary education was not a predictor of PD dementia (PD-CRS < 65) at V5 (OR = 3.31; p = 0.194). Cognitive function in Parkinson's disease is influenced by the level of education.

Indexed as

Cognitive DysfunctionEducational StatusParkinson DiseaseAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedCognitionCognitive reserveDementiaEducation levelParkinson’s disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.